You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

imatinib

Showing 1 - 25 of 909
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)

Not yet recruiting
  • Gastrointestinal Stromal Tumor of Rectum
  • Imatinib Mesylate
  • Local resection
  • Fuzhou, Fujian, China
    Weizhong Jiang
Jul 23, 2023

Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

Not yet recruiting
  • Inherited Bone Marrow Failure Syndrome
  • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
  • imatinib
  • TruSight Oncology
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 20, 2023

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Imatinib With Hepatic Resection or Other Local Treatment for

Completed
  • GIST, Malignant
  • Liver Metastases
  • imatinib (IM)
  • +3 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 12, 2023

CML Trial in Tempe (Imatinib Mesylate, IkT-001Pro)

Recruiting
  • CML
  • Tempe, Arizona
    Celerion
Nov 21, 2022

Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)

Completed
  • Gastrointestinal Stromal Tumors (GISTs)
  • Imatinib Mesylate
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

GIST Trial in Xi'an (Imatinib)

Recruiting
  • GIST
  • Imatinib
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Jun 8, 2023

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Imatinib 400 MG Oral Tablet
  • Gothenburg, Sweden
    Barbro Linderholm
Feb 1, 2023

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Imatinib Mesylate
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 22, 2022

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Gastrointestinal Stromal Tumors Trial in Lexington (Imatinib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Imatinib
  • Lexington, Kentucky
    Markey Cancer Center
Aug 5, 2022

Sarcoma Trial in Helsinki (Imatinib)

Recruiting
  • Sarcoma
  • Imatinib
  • Helsinki, Finland
    Helsinki University Central Hospital
Sep 26, 2022

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Imatinib
  • +3 more
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

GIST Trial (Ripretinib, Sunitinib)

Not yet recruiting
  • GIST
  • (no location specified)
Feb 8, 2023

Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic

Recruiting
  • Unresectable Gastrointestinal Stromal Tumor (GIST)
  • +2 more
  • Atezolizumab 1200 mg
  • Imatinib 400 MG
  • Lyon, Rhône, France
  • +4 more
Apr 28, 2022

Desmoid Tumor Trial in Seoul (vactosertib/imatinib combination)

Recruiting
  • Desmoid Tumor
  • vactosertib/imatinib combination
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Jun 14, 2022

Advanced, Refractory Cancer Trial in Seoul (Imatinib)

Active, not recruiting
  • Advanced, Refractory Cancer
  • Imatinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Melanoma Trial in Shinjuku (Pembrolizumab and Imatinib mesylate)

Recruiting
  • Melanoma
  • Pembrolizumab and Imatinib mesylate
  • Shinjuku, Tokyo, Japan
    Keio University Hospital
Mar 29, 2022

Effect of Pharmacogenetics on Imatinib Plasma Level and Response

Active, not recruiting
  • Chronic Myeloid Leukemia
  • PCR
  • HPLC-UV
  • Assiut, Egypt
    South Egypt Cancer Institute
Aug 6, 2022

Gastrointestinal Stromal Tumor Trial in Oslo (Discontinuation of imatinib)

Suspended
  • Gastrointestinal Stromal Tumor
  • Discontinuation of imatinib
  • Oslo, Norway
    Oslo University Hospital
Feb 7, 2022